117 related articles for article (PubMed ID: 27914769)
21. DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis.
De Gregoriis G; Ramos JA; Fernandes PV; Vignal GM; Brianese RC; Carraro DM; Monteiro AN; Struchiner CJ; Suarez-Kurtz G; Vianna-Jorge R; de Carvalho MA
Cancer Biol Ther; 2017 Jun; 18(6):439-449. PubMed ID: 28475402
[TBL] [Abstract][Full Text] [Related]
22. The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ.
Miligy IM; Toss MS; Shiino S; Oni G; Syed BM; Khout H; Tan QT; Green AR; Macmillan RD; Robertson JFR; Rakha EA
Br J Cancer; 2020 Nov; 123(10):1513-1520. PubMed ID: 32773767
[TBL] [Abstract][Full Text] [Related]
23. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
[TBL] [Abstract][Full Text] [Related]
24. PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement.
Bonin S; Pracella D; Barbazza R; Dotti I; Boffo S; Stanta G
Dis Markers; 2019; 2019():7832376. PubMed ID: 31781306
[TBL] [Abstract][Full Text] [Related]
25. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
26. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer.
Liu T; Zhang X; Shang M; Zhang Y; Xia B; Niu M; Liu Y; Pang D
J Surg Oncol; 2013 Feb; 107(2):188-94. PubMed ID: 22886823
[TBL] [Abstract][Full Text] [Related]
27. Nuclear localization of GLI1 and elevated expression of FOXC2 in breast cancer is associated with the basal-like phenotype.
Li Y; Yang W; Yang Q; Zhou S
Histol Histopathol; 2012 Apr; 27(4):475-84. PubMed ID: 22374725
[TBL] [Abstract][Full Text] [Related]
28. Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.
Alshareeda AT; Negm OH; Aleskandarany MA; Green AR; Nolan C; TigHhe PJ; Madhusudan S; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Aug; 159(1):41-53. PubMed ID: 27464795
[TBL] [Abstract][Full Text] [Related]
29. Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: a correlation with other biological parameters.
Lee WY; Jin YT; Chang TW; Lin PW; Su IJ
Histopathology; 1999 Feb; 34(2):106-12. PubMed ID: 10064388
[TBL] [Abstract][Full Text] [Related]
30. Constitutive expression of γ-H2AX has prognostic relevance in triple negative breast cancer.
Nagelkerke A; van Kuijk SJ; Sweep FC; Nagtegaal ID; Hoogerbrugge N; Martens JW; Timmermans MA; van Laarhoven HW; Bussink J; Span PN
Radiother Oncol; 2011 Oct; 101(1):39-45. PubMed ID: 21840613
[TBL] [Abstract][Full Text] [Related]
31. Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis.
Guarneri V; Barbieri E; Piacentini F; Giovannelli S; Ficarra G; Frassoldati A; Maiorana A; D'Amico R; Conte P
Int J Biol Markers; 2010; 25(2):104-11. PubMed ID: 20544688
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Malamou-Mitsi V; Gogas H; Dafni U; Bourli A; Fillipidis T; Sotiropoulou M; Vlachodimitropoulos D; Papadopoulos S; Tzaida O; Kafiri G; Kyriakou V; Markaki S; Papaspyrou I; Karagianni E; Pavlakis K; Toliou T; Scopa C; Papakostas P; Bafaloukos D; Christodoulou C; Fountzilas G
Ann Oncol; 2006 Oct; 17(10):1504-11. PubMed ID: 16968874
[TBL] [Abstract][Full Text] [Related]
33. Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer.
Toffoli S; Bar I; Abdel-Sater F; Delrée P; Hilbert P; Cavallin F; Moreau F; Van Criekinge W; Lacroix-Triki M; Campone M; Martin AL; Roché H; Machiels JP; Carrasco J; Canon JL
Breast Cancer Res; 2014 Nov; 16(6):466. PubMed ID: 25416589
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group.
Ahmed SS; Thike AA; Zhang K; Lim JC; Tan PH
J Clin Pathol; 2017 Apr; 70(4):320-326. PubMed ID: 27612503
[TBL] [Abstract][Full Text] [Related]
35. Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women.
Agboola AO; Banjo AA; Anunobi CC; Salami B; Agboola MD; Musa AA; Nolan CC; Rakha EA; Ellis IO; Green AR
ISRN Oncol; 2013; 2013():675051. PubMed ID: 23691362
[TBL] [Abstract][Full Text] [Related]
36. BRCA1 expression in triple negative sporadic breast cancers.
Galizia E; Giorgetti G; Piccinini G; Santinelli A; Loretelli C; Bianchi F; Gagliardini D; Carbonari G; Pisa E; Belvederesi L; Bracci R; Ferretti C; Corradini F; Cellerino R
Anal Quant Cytol Histol; 2010 Feb; 32(1):24-9. PubMed ID: 20701084
[TBL] [Abstract][Full Text] [Related]
37. Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa.
Awadelkarim KD; Arizzi C; Elamin EO; Hamad HM; De Blasio P; Mekki SO; Osman I; Biunno I; Elwali NE; Mariani-Costantini R; Barberis MC
Histopathology; 2008 Mar; 52(4):445-56. PubMed ID: 18315597
[TBL] [Abstract][Full Text] [Related]
38. Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry.
Choi J; Jung WH; Koo JS
Pathobiology; 2013; 80(1):41-52. PubMed ID: 22832328
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
Wang S; Li H; Wang J; Wang D; Yao A; Li Q
Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical Expression of BRCA1 Protein, ER, PR and Her2/neu in Breast Cancer: A Clinicopathological Study.
Hussein IA; Ahmed ST; Hameedi AD; Naji RZ; Alharbawi L; Alkhaytt M; Pity IS
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1025-1029. PubMed ID: 32334465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
